Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2020

01-02-2020 | Community-Acquired Pneumonia | Original Article

Cytokine levels predict 30-day mortality in octogenarians and nonagenarians with community-acquired pneumonia: a retrospective observational study

Authors: Héctor Pinargote-Celorio, Gemma Miralles, Miguel Cano, Esther Caparros, Joaquín Portilla, Gregorio González-Alcaide, José M. Ramos_Rincón

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2020

Login to get access

Abstract

To analyze the value of cytokines (tumor necrosis factor [TNF]-α, interleukin [IL]-1β, IL-6, IL-8, IL-10) as predictors of mortality at 30 days in octogenarians and nonagenarians hospitalized in an internal medicine unit for community-acquired pneumonia (CAP). An observational, analytical, retrospective cohort study was conducted in the Department of Internal Medicine at Alicante General University Hospital between January 2014 and December 2015. Blood samples were frozen at − 80 °C, and cytokines were measured by ELISA. We included 115 patients, of whom 54% were men, with a mean age of 86.4 (standard deviation 4.5) years. There is a moderate correlation between IL-10 levels and CURB-65 score (p < 0.001) and a weak correlation with creatinine levels (p = 0.012) and urea levels (p = 0.032). Forty-five (39.1%) patients died within 30 days. In a multivariate analysis, the variables associated with mortality at 30 days were the following: age (adjusted odds ratio [ORa] 1.134, 95% confidence interval [CI] 1.02, 1.26), male sex (ORa 2.85, 95% CI 1.14, 7.14), IL-8 of 19 pg/mL or more (ORa 4.09, 95% CI 1.67, 10.01), and IL-10 of 11.29 pg/mL or more (ORa 4.00, 95% CI 1.58, 10.12). High IL-8 and IL-10 levels were shown to predict 30-day mortality in elderly patients with CAP. The inflammatory response in these patients seems to condition their prognosis. Further research in this line would provide more understanding about the physiopathological mechanisms and potential therapeutic targets for improving survival.
Literature
1.
go back to reference Niu W-Y, Wan Y-G, Li M-Y, Wu Z-X, Zhang L-G, Wang J-X (2013) The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis. Eur Rev Med Pharmacol Sci 17:3329–3333PubMed Niu W-Y, Wan Y-G, Li M-Y, Wu Z-X, Zhang L-G, Wang J-X (2013) The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis. Eur Rev Med Pharmacol Sci 17:3329–3333PubMed
2.
go back to reference File TM (2019) Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults. In: Bartlett JG, Ramirez JA, editors. UpToDate. Waltham, Mass: UpToDate Inc; 2019. File TM (2019) Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults. In: Bartlett JG, Ramirez JA, editors. UpToDate. Waltham, Mass: UpToDate Inc; 2019.
7.
go back to reference Romero-Cabrera ÁJ, Amores-Hernández L (2013) Casteleiro EF-. Inmunosenescencia y fragilidad: una mirada actual. Med Interna México 29:605–611 Romero-Cabrera ÁJ, Amores-Hernández L (2013) Casteleiro EF-. Inmunosenescencia y fragilidad: una mirada actual. Med Interna México 29:605–611
18.
go back to reference Saldías Peñafiel F, O’Brien Solar A, Gederlini Gollerino A, Farías Gontupil G, Díaz FA (2003) Community-acquired pneumonia requiring hospitalization in immunocompetent elderly patients: clinical features, prognostic factors and treatment. Arch Bronconeumol 39:333–340CrossRef Saldías Peñafiel F, O’Brien Solar A, Gederlini Gollerino A, Farías Gontupil G, Díaz FA (2003) Community-acquired pneumonia requiring hospitalization in immunocompetent elderly patients: clinical features, prognostic factors and treatment. Arch Bronconeumol 39:333–340CrossRef
20.
go back to reference Petersen PT, Egelund GB, Jensen AV, Andersen SB, Pedersen MF, Rohde G et al (2018) Associations between biomarkers at discharge and co-morbidities and risk of readmission after community-acquired pneumonia: a retrospective cohort study. Eur J Clin Microbiol Infect Dis 29(37):1103–1111. https://doi.org/10.1007/s10096-018-3224-8 CrossRef Petersen PT, Egelund GB, Jensen AV, Andersen SB, Pedersen MF, Rohde G et al (2018) Associations between biomarkers at discharge and co-morbidities and risk of readmission after community-acquired pneumonia: a retrospective cohort study. Eur J Clin Microbiol Infect Dis 29(37):1103–1111. https://​doi.​org/​10.​1007/​s10096-018-3224-8 CrossRef
23.
go back to reference Hack CE, Hart M, Van Schijndel RJMS, Eerenberg AJM, Nuijens JH, Thijs LG et al (1992) Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60:2835–2842CrossRef Hack CE, Hart M, Van Schijndel RJMS, Eerenberg AJM, Nuijens JH, Thijs LG et al (1992) Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60:2835–2842CrossRef
24.
go back to reference Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W et al (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 69:307–316CrossRef Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W et al (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 69:307–316CrossRef
35.
go back to reference Rink L, Cakman I, Kirchner H (1998) Altered cytokine production in the elderly. Mech Ageing Dev 15(102):199–209CrossRef Rink L, Cakman I, Kirchner H (1998) Altered cytokine production in the elderly. Mech Ageing Dev 15(102):199–209CrossRef
Metadata
Title
Cytokine levels predict 30-day mortality in octogenarians and nonagenarians with community-acquired pneumonia: a retrospective observational study
Authors
Héctor Pinargote-Celorio
Gemma Miralles
Miguel Cano
Esther Caparros
Joaquín Portilla
Gregorio González-Alcaide
José M. Ramos_Rincón
Publication date
01-02-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03725-6

Other articles of this Issue 2/2020

European Journal of Clinical Microbiology & Infectious Diseases 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.